To Best Fight Cancer, New Guidelines Urge Exercise
FRIDAY, Nov. 5 (HealthDay News) -- People undergoing cancer treatment traditionally have been told to rest as much as possible and avoid exertion, to save all their strength to battle the dreaded disease.
Health Tip: NSAIDs Induce Ulcers in Some
(HealthDay News) -- Peptic ulcers are sores that form inside the stomach or intestines. Taking nonsteroidal anti-inflammatory drugs (NSAIDs) for chronic pain can contribute to NSAID-induced ulcers in some people, the American Gastroenterological Association says.
Health Tip: Don't Mix Alcohol and Drugs
(HealthDay News) -- It's never a good idea to drink alcohol while you're taking a medication, but there are certain over-the-counter drugs that can be particularly dangerous when taken with alcohol.
Falls, Not Gunshot, May Be Hunters' Biggest Threat
FRIDAY, Nov. 5 (HealthDay News) -- Falls from tree stands are the leading cause of hunter-related injuries, according to an Ohio State University study.
Older Brothers More Likely to Bully
FRIDAY, Nov. 5 (HealthDay News) -- Older brothers are more likely than older sisters to bully younger siblings, a new study finds.
Anti-Delirium Drug May Harm Critically Ill Patients
THURSDAY, Nov. 4 (HealthDay News) -- The anti-delirium drug rivastigmine (brand name Exelon) does not appear to control delirium in critically ill hospital patients, new Dutch research indicates.
Many U.S. Travelers Uninformed About Health Risks Abroad
FRIDAY, Nov. 5 (HealthDay News) -- About half of the 30 million Americans who travel each year to lower-income countries seek advice about potential health risks before heading abroad, new research shows.
Psychopaths May Lack Understanding of Social Contracts: Study
FRIDAY, Nov. 5 (HealthDay News) -- Impaired understanding of how social contracts work and why people need to take precautions may explain why psychopaths cheat and take risks even though they know right from wrong, a new study suggests.
Vitamin E May Pose Slight Bleeding-Stroke Risk
THURSDAY, Nov. 4 (HealthDay News) -- People who take vitamin E supplements may be putting themselves at a slight increased risk for a hemorrhagic stroke, researchers report.
Better Hepatitis C Surveillance Helps Public, CDC Finds
FRIDAY, Nov. 5 (HealthDay News) -- Enhanced surveillance of acute hepatitis C infections in the United States offers more timely and complete case reporting that provides greater benefits to public health, a new study concludes.
U.S. Obesity Rate May Hit 42% by 2050
FRIDAY, Nov. 5 (HealthDay News) -- Despite reports that the rate of obesity among U.S. adults might be slowing down, a new projection from Harvard University and MIT suggests otherwise.
Genetic Deletion Linked to Raised Risk of Autism, Schizophrenia
FRIDAY, Nov. 5 (HealthDay News) -- An international consortium of researchers has linked a regional abnormality found in a specific chromosome to a significantly increased risk for both autism spectrum disorders (ASD) and schizophrenia.
Lupus Kidney Disorder Treatment Improved Over Decade: Review
FRIDAY, Nov. 5 (HealthDay News) -- Over the past 10 years, treatment options for patients with an inflammatory kidney disorder known as lupus nephritis have vastly improved, according to a new review.
Research Suggests Link Between 'Handedness' and Dyslexia
FRIDAY, Nov. 5 (HealthDay News) -- New genetic mapping of children with reading difficulties suggests that those who carry a particular gene mutation are particularly well-skilled in the use of their right hand.
Health Highlights: Nov. 5, 2010
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
As Clocks Fall Back on Sunday, Think About Better Sleep
FRIDAY, Nov. 5 (HealthDay News) -- When you turn your clocks back an hour this weekend, it might be a good opportunity to think about whether you're getting enough sleep.
Clinical Trials Update: Nov. 5, 2010
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Cymbalta Approved for Chronic Joint and Muscle Pain
FRIDAY, Nov. 5 (HealthDay News) -- Cymbalta (duloxetine hydrochloride) has received expanded approval from the U.S. Food and Drug Administration to treat chronic musculoskeletal pain, stemming from conditions including lower back pain and osteoarthritis.
Kombiglyze XR Approved for Adult Type 2 Diabetes
FRIDAY, Nov. 5 (HealthDay News) -- The combination drug Kombiglyze (saxagliptin, metformin XR) has been approved by the U.S. Food and Drug Administration to help control blood sugar in adults with type 2 diabetes, makers AstraZeneca and Bristol-Myers Squibb said Friday.